Gasdermin D activation in oligodendrocytes and microglia drives inflammatory demyelination in progressive multiple sclerosis

Brain Behav Immun. 2024 Jan:115:374-393. doi: 10.1016/j.bbi.2023.10.022. Epub 2023 Oct 31.

Abstract

Neuroinflammation coupled with demyelination and neuro-axonal damage in the central nervous system (CNS) contribute to disease advancement in progressive multiple sclerosis (P-MS). Inflammasome activation accompanied by proteolytic cleavage of gasdermin D (GSDMD) results in cellular hyperactivation and lytic death. Using multiple experimental platforms, we investigated the actions of GSDMD within the CNS and its contributions to P-MS. Brain tissues from persons with P-MS showed significantly increased expression of GSDMD, NINJ1, IL-1β, and -18 within chronic active demyelinating lesions compared to MS normal appearing white matter and nonMS (control) white matter. Conditioned media (CM) from stimulated GSDMD+/+ human macrophages caused significantly greater cytotoxicity of oligodendroglial and neuronal cells, compared to CM from GSDMD-/- macrophages. Oligodendrocytes and CNS macrophages displayed increased Gsdmd immunoreactivity in the central corpus callosum (CCC) of cuprizone (CPZ)-exposed Gsdmd+/+ mice, associated with greater demyelination and reduced oligodendrocyte precursor cell proliferation, compared to CPZ-exposed Gsdmd-/- animals. CPZ-exposed Gsdmd+/+ mice exhibited significantly increased G-ratios and reduced axonal densities in the CCC compared to CPZ-exposed Gsdmd-/- mice. Proteomic analyses revealed increased brain complement C1q proteins and hexokinases in CPZ-exposed Gsdmd-/- animals. [18F]FDG PET imaging showed increased glucose metabolism in the hippocampus and whole brain with intact neurobehavioral performance in Gsdmd-/- animals after CPZ exposure. GSDMD activation in CNS macrophages and oligodendrocytes contributes to inflammatory demyelination and neuroaxonal injury, offering mechanistic and potential therapeutic insights into P-MS pathogenesis.

Keywords: Demyelination; FDG-PET; Gasdermin D; Microglia; Oligodendrocyte; Progressive multiple sclerosis; Proteomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Adhesion Molecules, Neuronal
  • Cuprizone / therapeutic use
  • Cuprizone / toxicity
  • Disease Models, Animal
  • Gasdermins* / metabolism
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Microglia / pathology
  • Multiple Sclerosis* / pathology
  • Multiple Sclerosis, Chronic Progressive* / pathology
  • Nerve Growth Factors
  • Oligodendroglia
  • Proteomics

Substances

  • Cell Adhesion Molecules, Neuronal
  • Cuprizone
  • Gasdermins
  • Nerve Growth Factors
  • NINJ1 protein, human
  • GSDMD protein, human
  • Gsdmd protein, mouse